Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy B London

Showing results (21-30 of 230) with videos related to

Pageof 23
Sort By:
Cancer Medicine|December 16, 2024
Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric OncologyHannah E Olsen, Pei-Chi Kao, Caleb Richmond, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification SystemArlene Naranjo, Meredith S Irwin, Michael D Hogarty, et al.
Clinical Pediatrics|November 19, 2021
Prevalence and Predictors of Iron Deficiency in Adolescent and Young Adult Outpatients: Implications for ScreeningRose Eiduson, Matthew M Heeney, Pei-Chi Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology GroupJennifer Schneiderman, Wendy B London, Garrett M Brodeur, et al.
Journal of Pediatric Surgery|June 9, 2004
Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group studyE Stanton Adkins, Robert Sawin, Robert B Gerbing, et al.
Journal of Pediatric Hematology/Oncology|July 11, 2006
Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology groupMichal A Miller, Kensuke Ohashi, Xiaoyan Zhu, et al.
Pediatric Blood & Cancer|November 1, 2022
Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectKevin Campbell, Pei-Chi Kao, Arlene Naranjo, et al.
Pediatric Blood & Cancer|December 19, 2007
Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology GroupA Lindsay Frazier, Pavlina Rumcheva, Thomas Olson, et al.
Pediatric Blood & Cancer|October 4, 2005
APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trialRobert S Wimmer, Allen R Chauvenet, Wendy B London, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2006
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of ageHideki Sano, Jeffrey Bonadio, Robert B Gerbing, et al.
Pageof 23

Showing results (21-30 of 230) with videos related to

Sort By:
Pageof 23
Cancer Medicine|December 16, 2024
Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric OncologyHannah E Olsen, Pei-Chi Kao, Caleb Richmond, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification SystemArlene Naranjo, Meredith S Irwin, Michael D Hogarty, et al.
Clinical Pediatrics|November 19, 2021
Prevalence and Predictors of Iron Deficiency in Adolescent and Young Adult Outpatients: Implications for ScreeningRose Eiduson, Matthew M Heeney, Pei-Chi Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology GroupJennifer Schneiderman, Wendy B London, Garrett M Brodeur, et al.
Journal of Pediatric Surgery|June 9, 2004
Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group studyE Stanton Adkins, Robert Sawin, Robert B Gerbing, et al.
Journal of Pediatric Hematology/Oncology|July 11, 2006
Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology groupMichal A Miller, Kensuke Ohashi, Xiaoyan Zhu, et al.
Pediatric Blood & Cancer|November 1, 2022
Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectKevin Campbell, Pei-Chi Kao, Arlene Naranjo, et al.
Pediatric Blood & Cancer|December 19, 2007
Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology GroupA Lindsay Frazier, Pavlina Rumcheva, Thomas Olson, et al.
Pediatric Blood & Cancer|October 4, 2005
APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trialRobert S Wimmer, Allen R Chauvenet, Wendy B London, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2006
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of ageHideki Sano, Jeffrey Bonadio, Robert B Gerbing, et al.
Pageof 23